Heinrich Emanuel Merck Award for Analytical Science Goes to Professor Francesco Ricci

Merck KGaA, Darmstadt, Germany today announced that Professor Francesco Ricci from the University of Rome, Tor Vergata, Italy, will receive the 2017 HEM Award.

01 Sep 2017 | Darmstadt, Germany
  • Italian chemist to win prestigious science award worth €15,000
  • Recognition of young researchers who develop new methods in chemical analysis

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that Professor Francesco Ricci from the University of Rome, Tor Vergata, Italy, will receive the 2017 Heinrich Emanuel Merck Award for Analytical Science of Merck KGaA, Darmstadt, Germany. The Italian chemist will receive the recognition worth €15,000 for his ground-breaking development of nature-inspired DNA-based nanodevices for sensing applications. The award ceremony will take place today within the scope of the analytical conference Euroanalysis at the Stockholm University in Sweden.

“Professor Ricci developed an innovative, highly selective bio-based assay-tool, which offers a crucial added value for rapid and inexpensive detection of biomarkers. It is relevant for medicinal research and will improve the quality of human life,” explained Klaus Griesar, head of science relations at Merck KGaA, Darmstadt, Germany. The awardee studied strategies of nature to develop sensors for diagnostic applications that employ the same mechanisms of biomolecular receptors. One “detection”-strategy of these receptors is a binding-induced conformational change. The shift of conformation occurs through the binding of a target molecule. Based on this natural recognition mechanism, Ricci’s research group used synthetic DNA oligonucleotides to develop optical and electrochemical sensors. These analytical devices are enabled to detect a wide range of antibodies, proteins and further analytes relevant in medicinal research. According to the jury the elucidated method presents a crucial advantage, as the detection of such markers originally required multiple steps, component-intensive processes and sophisticated laboratory equipment. In contrast, Ricci’s single-step method offers a rapid and inexpensive detection while still providing high selectivity.

Born in 1977, Ricci studied chemistry at the University of Rome, Tor Vergata, and the University of Lund in Sweden. He earned his PhD degree in Analytical Chemistry at the University of Rome, Tor Vergata, in 2005 for his thesis on “Prussian Blue”-based sensors and biosensors. A year later, he became Senior Researcher at the Chemistry Department of the University of Rome, Tor Vergata. From 2006 to 2013, Ricci spent several visiting periods - two years in total - as a post-doc researcher in the Chemistry and Biochemistry Department at the University of California, Santa Barbara (UCSB), United States. In June 2013, he filled the position as Visiting Professor in the same department at the UCSB supported by the Marie Curie Outgoing Fellowship. Since April 2014, Ricci is Associate Professor at the Laboratory of Biosensors and Nanomachines of the Chemistry Department at the University of Rome, Tor Vergata.

Since 1988, the Heinrich Emanuel Merck Award of Merck KGaA, Darmstadt, Germany has been recognizing scientists under the age of 45 whose work focuses on new methods in chemical analysis and the development thereof in applications aimed at improving the quality of human life, for example in fields such as life science, environmental protection and the biosciences.


Friederike Segeberg

Heinrich Emanuel Merck Award – previous winners

Merck KGaA, Darmstadt, Germany began granting the Heinrich-Emanuel-Merck Award of Merck KGaA, Darmstadt, Germany in 1988 to mark the centennial of the first standardization of analytical methods by Dr. Karl Krauch, a Merck KGaA, Darmstadt, Germany chemist. This list of the prizewinners documents the significance of the prize in the analytical sciences community, which has often laid the groundwork for important discoveries.

Former Award winners are:

1988       Professor M. Hiraide, Japan; Professor O.S. Wolfbeis, Austria

1990       Dr. B. Bidlingmeyer, USA; Professor R. Niessner, Germany

1993       Professor A. Amirav, Israel

1996       Professor D.J. Harrison, Canada; Professor A. Manz, United Kingdom

1998       Professor R. Zenobi, Switzerland

2000       Professor N. Dovichi, Canada

2002       Professor J.V. Sweedler, USA

2004       Professor Y. Baba, Japan

2007       Dr. A. Makarov, Germany; Professor S. Nie, USA

2010       Professor Luisa Torsi, Italy

2012       Professor Aaron Wheeler, Canada

2015       Professor Petra Dittrich, Switzerland

All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.

About Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck KGaA, Darmstadt, Germany, generated sales of € 15.0 billion in 66 countries.

Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the „Merck KGaA, Darmstadt, Germany” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Related News

  1. Press Releases

    MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance PD ...

    SMC® immunoassay technology from MilliporeSigma provides new understanding of cell dysfunction to slow disease progression.